Stephen Bronson

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

Matthew C. Altman, M. Altman, Andrew G. Ayars, 2017, The journal of allergy and clinical immunology. In practice.